We are live on ! Find out more
BG

Bahl & Gaynor Portfolio holdings

AUM $19.8B
1-Year Est. Return 19.53%
This Fund
S&P 500
This Quarter Est. Return
+4.56%
1 Year Est. Return
+19.53%
3 Year Est. Return
+63.97%
5 Year Est. Return
+84.2%
10 Year Est. Return
+296.44%
AUM
$7.71B
AUM Growth
+$182M
Cap. Flow
-$102M
Cap. Flow %
-1.32%
Top 10 Hldgs %
27.14%
Holding
420
New
12
Increased
175
Reduced
164
Closed
17

Top Buys

Rank Stock Value
1
TXN icon
Texas Instruments
TXN
+$73.9M
2
MDT icon
Medtronic
MDT
+$52.6M
3
TFC icon
Truist Financial
TFC
+$30.9M
4
JNJ icon
Johnson & Johnson
JNJ
+$11.1M
5
HON icon
Honeywell
HON
+$10.3M

Top Sells

Rank Stock Value
1
ADI icon
Analog Devices
ADI
+$66.7M
2
SJM icon
J.M. Smucker
SJM
+$57.4M
3
KMB icon
Kimberly-Clark
KMB
+$35.4M
4
NVS icon
Novartis
NVS
+$19.8M
5
WEC icon
WEC Energy
WEC
+$5.61M

Sector Composition

Rank Sector Weight
1 Consumer Staples 16.9%
2 Healthcare 15.69%
3 Technology 15.19%
4 Financials 12.45%
5 Industrials 12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HSY icon
126
Hershey
HSY
$35.2B
$3.24M 0.04%
28,527
-2,780
-9% -$260K
PSX icon
127
Phillips 66
PSX
$84.9B
$3.23M 0.04%
40,697
+174
+0.4% +$14.2K
THO icon
128
Thor Industries
THO
$3.9B
$3.21M 0.04%
49,612
-1,699
-3% -$109K
GILD icon
129
Gilead Sciences
GILD
$162B
$3.21M 0.04%
38,465
-1,575
-4% -$140K
PACW
130
DELISTED
PacWest Bancorp
PACW
$3.2M 0.04%
80,402
-2,221
-3% -$87.1K
EFA icon
131
iShares MSCI EAFE ETF
EFA
$78B
$3.18M 0.04%
56,936
-576
-1% -$33.1K
VFC icon
132
VF Corp
VFC
$5.63B
$3.15M 0.04%
54,504
-1,368
-2% -$80.9K
BCPC
133
Balchem Corp
BCPC
$5.38B
$3.07M 0.04%
51,522
-10,575
-17% -$647K
HMN icon
134
Horace Mann Educators
HMN
$2.1B
$3.06M 0.04%
90,595
+9,040
+11% +$294K
WST icon
135
West Pharmaceutical
WST
$24B
$3.01M 0.04%
39,704
+2,160
+6% +$157K
TXRH icon
136
Texas Roadhouse
TXRH
$13.5B
$2.93M 0.04%
64,274
-3,517
-5% -$156K
HDV
137
iShares Core High Dividend ETF
HDV
$14.5B
$2.9M 0.04%
176,710
+4,875
+3% +$77.6K
IBM icon
138
IBM
IBM
$211B
$2.86M 0.04%
19,695
-341
-2% -$48.8K
RDS.A
139
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$2.81M 0.04%
50,927
-865
-2% -$44K
DEO icon
140
Diageo
DEO
$49B
$2.77M 0.04%
24,588
-741
-3% -$80.1K
ES icon
141
Eversource Energy
ES
$26.9B
$2.76M 0.04%
46,003
+83
+0.2% +$4.69K
SO icon
142
Southern Company
SO
$109B
$2.75M 0.04%
51,368
+649
+1% +$32.6K
DSI icon
143
iShares MSCI KLD 400 Social ETF
DSI
$5.3B
$2.74M 0.04%
70,732
+9,332
+15% +$359K
GS icon
144
Goldman Sachs
GS
$300B
$2.69M 0.03%
18,086
-15,772
-47% -$2.46M
WAB icon
145
Wabtec
WAB
$49.1B
$2.65M 0.03%
37,721
+455
+1% +$35.4K
COHR icon
146
Coherent
COHR
$51.4B
$2.63M 0.03%
140,282
-250
-0.2% -$5.11K
ISRG icon
147
Intuitive Surgical
ISRG
$127B
$2.56M 0.03%
34,767
BCR
148
DELISTED
CR Bard Inc.
BCR
$2.55M 0.03%
10,837
-155
-1% -$33.7K
VAL
149
DELISTED
Valspar
VAL
$2.49M 0.03%
23,066
WMT icon
150
Walmart Inc
WMT
$885B
$2.43M 0.03%
99,999
-5,712
-5% -$132K

Similar funds

Bahl & Gaynor's Q2 2016 Portfolio in Review

As of Q2 2016, Bahl & Gaynor held 420 positions worth $7.71B, up 2.4% from $7.53B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Bahl & Gaynor's Q2 2016 filing shows 12 new, 175 increased, 164 reduced and 17 closed positions. Its largest new stake was Simpson Manufacturing: 23,694 shares worth $947K. The largest sale was Analog Devices, an estimated $66.7M.

By sector, the portfolio is most concentrated in Consumer Staples at 17% of assets, down from 19% a quarter earlier, followed by Healthcare and Technology.

  • Bahl & Gaynor's largest Q2 2016 buy was Simpson Manufacturing: 23,694 shares worth $947K.
  • Bahl & Gaynor added most to Texas Instruments in Q2 2016, an estimated $73.9M increase.
  • Bahl & Gaynor's biggest Q2 2016 reduction was Analog Devices, cutting an estimated $66.7M.
  • Bahl & Gaynor fully exited Airgas Inc in Q2 2016, selling an estimated $3.17M.
  • Bahl & Gaynor's ten largest holdings make up 27% of its $7.71B portfolio in Q2 2016.
  • Bahl & Gaynor opened 12 new positions and closed 17 in Q2 2016.
  • Bahl & Gaynor's portfolio value rose 2.4% quarter-over-quarter to $7.71B.

Based on Bahl & Gaynor's 13F filing for Q2 2016, filed 10 Aug 2016.